Multiple sclerosis (MS) is an autoimmune disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. Being a demyelinating...
172 KB (18,188 words) - 04:29, 16 September 2024
Tumefactive multiple sclerosis is a condition in which the central nervous system of a person has multiple demyelinating lesions with atypical characteristics...
34 KB (4,286 words) - 01:29, 13 September 2024
Nucleus Node of Ranvier Axon terminal Schwann cell Myelin sheath Multiple sclerosis is an inflammatory demyelinating disease of the CNS in which activated...
76 KB (9,025 words) - 04:22, 25 March 2024
acute multiple sclerosis, also known as Marburg multiple sclerosis or acute fulminant multiple sclerosis, is considered one of the multiple sclerosis borderline...
9 KB (808 words) - 05:12, 13 December 2023
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS). Several therapies for it exist,...
131 KB (14,018 words) - 08:00, 24 June 2024
The signs and symptoms of multiple sclerosis (MS) encompass a wide range of neurological and physical manifestations, including vision problems, muscle...
75 KB (8,205 words) - 03:24, 15 August 2024
Multiple sclerosis (MS) can be pathologically defined as the presence of distributed glial scars (scleroses) in the central nervous system that must show...
143 KB (17,202 words) - 04:12, 17 July 2024
There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...
83 KB (9,405 words) - 11:49, 23 August 2024
Malignant multiple sclerosis is used to describe MS patients who reach significant level of disability in a short period of time. Malignant MS cases are...
8 KB (901 words) - 21:06, 15 August 2023
Current standards for diagnosing multiple sclerosis (MS) are based on the 2018 revision of McDonald criteria. They rely on MRI detection (or clinical demonstration)...
32 KB (3,285 words) - 19:50, 14 June 2024
Multiple Sclerosis Society may refer to: The Multiple Sclerosis Society of Great Britain The Multiple Sclerosis Society of Canada The National Multiple...
308 bytes (65 words) - 10:21, 4 September 2015
Several biomarkers for diagnosis of multiple sclerosis, disease evolution and response to medication (current or expected) are under research. While most...
66 KB (7,797 words) - 16:19, 8 June 2024
The National Multiple Sclerosis Society (NMSS) is an American nonprofit organization founded in 1946. It is an organization dedicated to supporting individuals...
11 KB (1,139 words) - 07:42, 4 June 2024
This is a list of notable people with multiple sclerosis, a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal...
39 KB (2,892 words) - 06:33, 25 August 2024
disease that most often affects the vulva and the penis. Multiple sclerosis, or focal sclerosis, is a central nervous system disease which affects coordination...
4 KB (291 words) - 05:37, 2 August 2024
Inflammatory demyelinating diseases of the central nervous system (redirect from Multiple sclerosis borderline)
often grouped together under Multiple Sclerosis. They are sometimes considered different diseases from Multiple Sclerosis, but considered by others to...
102 KB (11,716 words) - 02:04, 12 July 2024
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying...
68 KB (7,884 words) - 03:13, 19 August 2024
Cladribine (section History in multiple sclerosis)
treatment of adults with highly active forms of relapsing-remitting multiple sclerosis. Cladribine is a purine analogue that selectively targets and suppresses...
43 KB (4,492 words) - 00:15, 27 August 2024
The Multiple Sclerosis Functional Composite (MSFC) is a clinical trial outcome measure of assessing the severity of multiple sclerosis primarily used in...
3 KB (275 words) - 21:53, 3 December 2023
Brenda Banwell (section Research in Multiple Sclerosis)
University of Pennsylvania. Banwell is the co-director of the Pediatric Multiple Sclerosis and Neuroinflammatory Disorders Clinic at the Children's Hospital...
17 KB (1,734 words) - 06:25, 20 August 2024
of multiple sclerosis organizations in different countries around the world. Multiple Sclerosis International Federation European Multiple Sclerosis Platform...
1 KB (63 words) - 22:42, 12 April 2024
Multiple Sclerosis Australia, or MS Australia, is a national non-profit organization in Australia that coordinates and allocates funds for multiple sclerosis...
12 KB (1,021 words) - 10:27, 4 March 2024
Oligoclonal band (category CS1 maint: multiple names: authors list)
in the CSF of more than 95% of patients with clinically definite multiple sclerosis. Two methods of analysis are possible: (a) protein electrophoresis...
21 KB (2,556 words) - 18:03, 12 February 2024
ALS (redirect from Amyotropic lateral sclerosis)
Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND) or Lou Gehrig's disease in the United States, is a rare, terminal neurodegenerative...
131 KB (14,040 words) - 05:34, 13 September 2024
The Multiple Sclerosis Trust (MS Trust) is an independent, national UK charity that was established in 1993 by Chris Jones, who lives with MS and her good...
3 KB (343 words) - 12:28, 11 June 2024
The Multiple Sclerosis International Federation (MSIF) was established in 1967 as an international body linking the activities of various national MS societies...
5 KB (574 words) - 13:32, 5 August 2024
The Multiple Sclerosis Journal (formerly Multiple Sclerosis) is a monthly peer-reviewed medical journal covering the clinical neurology of multiple sclerosis...
3 KB (192 words) - 03:42, 27 April 2023
Natalizumab (section Multiple sclerosis)
the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease. It is a humanized monoclonal antibody against...
43 KB (3,967 words) - 04:10, 13 June 2024
BG-12, an oral fumarate, which was being studied for the treatment of multiple sclerosis and psoriasis. In January 2007, the company announced it would acquire...
48 KB (3,837 words) - 18:51, 12 September 2024
Alemtuzumab (section Multiple sclerosis)
others, is a medication used to treat chronic lymphocytic leukemia and multiple sclerosis. In chronic lymphocytic leukemia, it has been used as both a first...
19 KB (1,903 words) - 02:49, 24 August 2024